VGNX -- Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX -- Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (111)	1/19/2002 12:15:51 AM
From: tuck	Read Replies (1) of 269

No, no, don't tell me, let me guess . . . The cross post has to do with a drug that competes with a Vertex program. PEGging seems to improve certain aspects of PK/PD and safety for this drug. But in both versions, there's a lot of variation in the responses that may have something to do with the different haplotypes of the volunteers. Thus, if the competitor had any brains, it would sign a deal with VGNX to address these annoying variations. How'd I do? Off to Joshua Tree for the long weekend, even though it be a mite chilly. Taking the camera. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next